Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInchcape Regulatory News (INCH)

Share Price Information for Inchcape (INCH)

Share Price is delayed by 15 minutes
Get Live Data
804.00    -8.50 (-1.05%)
Bid:
798.50
Ask:
813.50
Spread: 15.00 (1.879%)
Market Cap: £2.83b
INCH Live PriceLast checked at - London Stock Exchange

Intraday Inchcape Share Chart

Update Statement

4 Nov 2025 12:05

RNS Number : 1370G
Inchcape PLC
04 November 2025
 

Inchcape plc

Update Statement

 

At the Annual General Meeting of Inchcape plc ("the Company") held on 15 May 2025, the resolution to approve the Directors' Remuneration Report (resolution 2) passed with 64.55% of votes in favour.

In accordance with Provision 4 of the FRC's 2024 UK Corporate Governance Code, the Company has released this statement to provide an update to shareholders on the actions taken and the views received from shareholders, following the vote.

Prior to the 2025 AGM, the Board of Directors consulted with our largest shareholders and with shareholders' proxy advisers on the Remuneration Committee's implementation decisions in respect of executive remuneration for 2025.

Some shareholders expressed a concern with the salary increase for the Group Chief Executive, which was above workforce average, and the stretch in the performance targets for the one-off PSP award.

Following the AGM, the Chair of the Remuneration Committee wrote to the top 50 shareholders, representing c. 80% of the issued share capital, to provide further rationale for the Remuneration Committee's decisions on these matters. This included a detailed overview of the Group Chief Executive's strategic achievements and the performance required for the one-off PSP targets over the next three years, both of which are integral to the successful execution of the Accelerate+ strategy. Having considered feedback received, the Board is satisfied with its decisions and has concluded that no further actions are necessary.

Also, as part of this consultation, shareholders were also invited to provide their views on proposals for the Remuneration Policy which will be put to shareholder vote at the 2026 AGM. This consultation is on-going, and the feedback received so far, and in respect of the 2024 Remuneration Report, has been helpful in formulating the proposals for the 2026 policy.

The Board is grateful to shareholders for their engagement, and the Board will continue its constructive dialogue with shareholders, considering their feedback when setting remuneration.

An update will be published in our 2025 Annual Report in accordance with the UK Corporate Governance Code, along with the 2026 Remuneration Policy which will be put to shareholder vote at the 2026 AGM.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMUPGWUGUPAGPC
Date   Source Headline
1st Aug 20247:00 amRNSCompletion of disposal of UK Retail Business
1st Aug 20247:00 amRNSShare buyback programme
30th Jul 20247:00 amRNSHalf-year Report
23rd Jul 20249:00 amRNSHolding(s) in Company
21st Jun 20242:59 pmRNSDirector/PDMR Shareholding
13th Jun 202411:36 amRNSDirector/PDMR Shareholding
11th Jun 20244:49 pmRNSDirector/PDMR Shareholding
31st May 20242:45 pmRNSDirector/PDMR Shareholding
23rd May 20247:00 amRNSInvestor and Analyst webinar
9th May 20241:05 pmRNSResult of AGM
8th May 20243:43 pmRNSDirector/PDMR Shareholding
25th Apr 20247:00 amRNS1st Quarter Results
15th Apr 20247:00 amRNSDisposal of UK Retail operations
11th Apr 202412:19 pmRNSCo-investment Plan: Director/PDMR Shareholding
11th Apr 202412:14 pmRNSPerformance Share Plan: Director/PDMR Shareholding
4th Apr 20241:55 pmRNSDirector/PDMR Shareholding
3rd Apr 20245:08 pmRNSDirector/PDMR Shareholding
28th Mar 20247:09 amRNSAnnual Financial Report and Notice of AGM
12th Mar 20242:37 pmRNSDirector/PDMR Shareholding
11th Mar 20243:54 pmRNSDirector/PDMR Shareholding
8th Mar 20242:49 pmRNSDirector/PDMR Shareholding
7th Mar 20249:13 amRNSDirector/PDMR Shareholding
5th Mar 20245:07 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFY 2023 Preliminary Results
1st Feb 20243:24 pmRNSDirectorate Change
29th Jan 20243:47 pmRNSResponse to media reports
20th Dec 202312:37 pmRNSDirector/PDMR Shareholding
14th Dec 202312:00 pmRNSDirectorate Change
17th Nov 202311:10 amRNSDirector/PDMR Shareholding
26th Oct 20237:00 amRNS3rd Quarter Results
29th Sep 20238:10 amRNSDirector Declaration
11th Sep 202311:32 amRNSDirector/PDMR Shareholding
5th Sep 20232:26 pmRNSDirector/PDMR Shareholding
22nd Aug 20239:06 amRNSDirector/PDMR Shareholding
17th Aug 20233:48 pmRNSDirector/PDMR Shareholding
14th Aug 202311:56 amRNSDirector/PDMR Shareholding
4th Aug 20235:14 pmRNSDirector/PDMR Shareholding
2nd Aug 20232:51 pmRNSDirector/PDMR Shareholding
2nd Aug 20239:41 amRNSDirector/PDMR Shareholding
2nd Aug 20239:20 amRNSDirector/PDMR Shareholding
28th Jul 20234:36 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNSHalf-year Report
12th Jul 20234:26 pmRNSDirectorate Change
30th Jun 20237:00 amRNSGlobal Strategic Partnership with GWM
21st Jun 202312:23 pmRNSDirector/PDMR Shareholding
19th Jun 20234:24 pmRNSDirector/PDMR Shareholding
6th Jun 20239:22 amRNSDirector/PDMR Shareholding
5th Jun 20237:00 amRNSBond Offering
26th May 202311:36 amRNSBond Offering
24th May 20237:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.